Security key
039014303
- Security type / class
- Equity / Common
- Total 13F shares
- 161,885
- Total 13F value
- $1,209,095
- Share change
- +161,885
- SEC-reported price per share
- $7.47
- Number of holders
- 13
- Value change
- +$1,209,095
- Number of buys
- 13
- Shares outstanding
- 2,676,597
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
13
Top holders
10
RKDA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Arcadia Biosciences, Inc. SEC filings
Arcadia Biosciences, Inc. company facts
Arcadia Biosciences, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 039014303
Recent filing periods:
Ownership snapshot
Top reported holders of RKDA - Arcadia Biosciences, Inc. - Common (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 26%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 26%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
26%
VANGUARD GROUP INC
15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
14%
MILLENNIUM MANAGEMENT LLC
9%
CITADEL ADVISORS LLC
8.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
26%
|
$145,661
537,494 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
15%
|
$83,278
307,300 shares
|
— | 31 Dec 2022 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
14%
|
$76,536
282,419 shares
|
— | 31 Dec 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
9%
|
$50,000
185,438 shares
|
— | 31 Dec 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
8.8%
|
$49,169
181,437 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
8.6%
|
$48,000
177,475 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
161,885
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2026 Across Filers
Q1 2026 holders
15
Q1 2023 holders
13
Holder diff
-2
| Investor | Q1 2026 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend